Diabetol Metab Syndr. 2016 Feb 12;8:10. doi: 10.1186/s13098-016-0127-7. eCollection 2016.
Relationship between deep subcutaneous abdominal adipose tissue and metabolic syndrome: a case control study.
Diabetology & metabolic syndrome
Se-Hong Kim, Ju-Hye Chung, Sang-Wook Song, Won Sang Jung, Yun-Ah Lee, Ha-Na Kim
Affiliations
Affiliations
- Department of Family Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, 93-6 Ji-dong, Paldal-Gu, Suwon, Kyonggi-do 442-723 Republic of Korea.
- Department of Family Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 271, Cheon Bo-ro, Uijeongbu, Gyeonggi-do 480-717 Republic of Korea.
- Department of Radiology, College of Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, 93-6 Ji-dong, Paldal-Gu, Suwon, Kyonggi-do 442-723 Republic of Korea.
PMID: 26877772
PMCID: PMC4751727 DOI: 10.1186/s13098-016-0127-7
Abstract
BACKGROUND: The deep subcutaneous adipose tissue (dSAT) is closely related to the obesity-associated complications similarly to the characteristics of visceral adipose tissue (VAT). However, the association between dSAT and metabolic syndrome (MS) is unclear. The purpose of our study was to evaluate the association of distinct abdominal adipose tissue with the cardiometabolic risk factors and MS.
METHODS: Abdominal computed tomography (CT) images were obtained in 365 asymptomatic subjects (187 subjects with MS and 178 without MS). The axial images segmented into superficial and deep SAT by manually tracing the fascia superficialis at L4-5 levels. The concentrations of serum inflammatory cytokines and adipokines were also measured.
RESULTS: The MS group had significantly lower adiponectin levels but significantly higher levels of resistin, leptin, tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), intercellular adhesion molecule (ICAM), monocyte chemotactic protein-1 (MCP-1), and oxLDL than the control group (p < 0.05). All inflammatory cytokines and adipokines were associated with the sum of VAT and dSAT areas (VDAT) (P for trend < 0.05), but no significant correlation was found between inflammatory cytokines and sSAT. dSAT was significantly associated with MS in both men and women (OR 2.371; p < 0.001) whereas the ORs between sSAT and MS were not significant (p = 0.597). The age-adjusted ORs between VDAT and MS (OR of 8.359 in men and 3.183 in women, p < 0.001) were higher than those of VAT (OR of 7.941 in men and 2.570 in women, p < 0.05) and dSAT (OR of 2.954 in men and 1.856 in women, p < 0.05).
CONCLUSIONS: We demonstrated that dSAT was associated with increased inflammation and oxidative stress, suggesting that dSAT is an important determinant of MS. Therefore, abdominal subcutaneous fat should be considered as two functionally distinct compartments rather than a single entity.
Keywords: Adipocytokine; Deep subcutaneous adipose tissue; Inflammatory cytokine; Metabolic syndrome; Superficial subcutaneous adipose tissue; Visceral adipose tissue
References
- Obesity (Silver Spring). 2008 Sep;16(9):1983-91 - PubMed
- Metabolism. 2008 Apr;57(4):506-10 - PubMed
- Diabetes Care. 2007 Feb;30(2):286-91 - PubMed
- Circ J. 2006 Nov;70(11):1437-42 - PubMed
- Obes Res. 2003 Aug;11(8):997-1001 - PubMed
- Eur J Endocrinol. 2007 Feb;156(2):279-84 - PubMed
- Diabetes Care. 2014;37(3):821-9 - PubMed
- Am J Physiol Endocrinol Metab. 2000 May;278(5):E941-8 - PubMed
- Metabolism. 2003 Oct;52(10):1274-8 - PubMed
- Diabetologia. 2007 Aug;50(8):1707-15 - PubMed
- Obesity (Silver Spring). 2013 Dec;21(12):2562-70 - PubMed
- Diabetes. 1997 Oct;46(10):1579-85 - PubMed
- Diabetes. 2004 Aug;53(8):2087-94 - PubMed
- Clin Biochem. 2011 Mar;44(4):281-7 - PubMed
- Nature. 2006 Dec 14;444(7121):881-7 - PubMed
- Int J Cardiol. 2005 Jun 8;101(3):385-90 - PubMed
- Intern Emerg Med. 2010 Apr;5(2):111-9 - PubMed
- Endocrine. 2014 May;46(1):99-106 - PubMed
- Horm Mol Biol Clin Investig. 2014 Jul;19(1):57-74 - PubMed
- Metabolism. 2001 Apr;50(4):425-35 - PubMed
- Int J Obes (Lond). 2013 Apr;37(4):620-2 - PubMed
- Transl Res. 2010 Feb;155(2):71-7 - PubMed
- Circulation. 2007 Sep 11;116(11):1234-41 - PubMed
- Rev Esp Cardiol. 2006 Dec;59(12):1252-60 - PubMed
- Diabetes Care. 2012 Mar;35(3):640-7 - PubMed
- Diabetologia. 2005 Nov;48(11):2330-3 - PubMed
- Obes Res. 2002 Apr;10(4):266-9 - PubMed
- Obesity (Silver Spring). 2007 Aug;15(8):1933-43 - PubMed
- Circulation. 2005 Oct 25;112(17):2735-52 - PubMed
- J Hepatol. 2012 May;56(5):1152-8 - PubMed
- Circulation. 2007 Jul 3;116(1):39-48 - PubMed
- Eur J Clin Invest. 2000 Apr;30(4):302-10 - PubMed
- Obes Res. 2003 Mar;11(3):469-76 - PubMed
- Metabolism. 2008 May;57(5):644-9 - PubMed
- JAMA. 2002 Dec 4;288(21):2709-16 - PubMed
- Diabetes Metab Res Rev. 2009 Nov;25(8):733-9 - PubMed
- Arterioscler Thromb Vasc Biol. 1997 Jul;17(7):1472-80 - PubMed
- J Int Med Res. 2009 Nov-Dec;37(6):1803-12 - PubMed
- Circulation. 2005 Feb 22;111(7):932-9 - PubMed
- ARYA Atheroscler. 2011 Winter;6(4):140-3 - PubMed
Publication Types